Orchid Pharma Limited (ORCHPHARMA.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 24.48B |
| Enterprise Value | 28.03B |
| P/E Ratio | 575.12 |
| PEG Ratio | -6.4 |
| Price/Sales Ratio | 5.29 |
| Price/Book Ratio | 3.87 |
| Enterprise/Revenue | 5.29 |
| Enterprise/EBITDA | 99.32 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.01 |
| Operating Margin | 0.04 |
AD
Management Effectiveness
| Return On Assets | 0 |
| Return On Equity | 0.01 |
Income Statement
| Revenue | 8.11B |
| Revenue/Share | 185.84 |
| Gross Profit | 1.59B |
| EBITDA | 411.28M |
| Net Income | 205.47M |
| Diluted EPS | 4.05 |
Balance Sheet
| Total Cash | 832.11M |
| Total Cash/Share | 0 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 0 |
| Book Value Per Share | 253.91 |
Price History
| 52-Week Change | 32.18 |
| 52-Week High | 1,143.5 |
| 52-Week Low | 480 |
| Moving Average 50 Days | 1,003.41 |
| Moving Average 200 Days | 793.34 |
Statistics
| Average Volume | 174,789 |
| Shares Outstanding | 50.72M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:218 |
| Last Split Date | July 25, 2019 |
AD
